Unigestion Holding SA Sells 1,036 Shares of Varian Medical Systems, Inc. (NYSE:VAR)

Unigestion Holding SA cut its position in Varian Medical Systems, Inc. (NYSE:VAR) by 25.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,041 shares of the medical equipment provider’s stock after selling 1,036 shares during the quarter. Unigestion Holding SA’s holdings in Varian Medical Systems were worth $362,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Arrow Financial Corp bought a new stake in shares of Varian Medical Systems during the 2nd quarter valued at $27,000. Quantamental Technologies LLC bought a new stake in shares of Varian Medical Systems during the 2nd quarter valued at $29,000. Financial Gravity Wealth Inc. raised its stake in shares of Varian Medical Systems by 1,646.2% during the 2nd quarter. Financial Gravity Wealth Inc. now owns 227 shares of the medical equipment provider’s stock valued at $31,000 after purchasing an additional 214 shares during the period. Flagship Harbor Advisors LLC bought a new stake in shares of Varian Medical Systems during the 2nd quarter valued at $32,000. Finally, FinTrust Capital Advisors LLC raised its stake in shares of Varian Medical Systems by 651.6% during the 2nd quarter. FinTrust Capital Advisors LLC now owns 233 shares of the medical equipment provider’s stock valued at $32,000 after purchasing an additional 202 shares during the period. Hedge funds and other institutional investors own 91.48% of the company’s stock.

In other Varian Medical Systems news, SVP John W. Kuo sold 465 shares of the company’s stock in a transaction dated Monday, August 19th. The stock was sold at an average price of $110.49, for a total value of $51,377.85. Following the transaction, the senior vice president now directly owns 35,566 shares in the company, valued at approximately $3,929,687.34. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders sold a total of 1,395 shares of company stock worth $158,388 over the last 90 days. Corporate insiders own 0.78% of the company’s stock.

NYSE VAR traded up $1.30 during trading on Friday, reaching $124.76. The company’s stock had a trading volume of 488,581 shares, compared to its average volume of 665,692. The stock has a market capitalization of $11.27 billion, a PE ratio of 26.95, a P/E/G ratio of 2.87 and a beta of 0.87. The firm has a fifty day moving average of $117.33 and a 200 day moving average of $123.18. Varian Medical Systems, Inc. has a one year low of $103.92 and a one year high of $142.50.

Varian Medical Systems (NYSE:VAR) last announced its earnings results on Wednesday, October 23rd. The medical equipment provider reported $1.21 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.21. The business had revenue of $878.90 million for the quarter, compared to analyst estimates of $858.47 million. Varian Medical Systems had a return on equity of 24.42% and a net margin of 9.65%. The company’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same period in the prior year, the company earned $1.16 EPS. As a group, equities analysts forecast that Varian Medical Systems, Inc. will post 5.39 earnings per share for the current year.

A number of analysts recently issued reports on VAR shares. TheStreet lowered Varian Medical Systems from a “b” rating to a “c+” rating in a research note on Monday, August 5th. ValuEngine lowered Varian Medical Systems from a “buy” rating to a “hold” rating in a research note on Tuesday, August 20th. BTIG Research upgraded Varian Medical Systems from a “neutral” rating to a “buy” rating and set a $130.00 price objective on the stock in a research note on Monday, October 14th. Robert W. Baird set a $158.00 target price on Varian Medical Systems and gave the stock a “buy” rating in a research note on Friday, July 26th. Finally, Zacks Investment Research lowered Varian Medical Systems from a “strong-buy” rating to a “hold” rating and set a $139.00 target price on the stock. in a research note on Saturday, July 27th. Three investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $145.11.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment.

Further Reading: Channel Trading

Want to see what other hedge funds are holding VAR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Varian Medical Systems, Inc. (NYSE:VAR).

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.